Medical News

RSS

St. Jude Medical's Epiducer lead delivery system for neurostimulation therapy receives CE Mark approval

St. Jude Medical, Inc., a global medical device company, today announced European CE Mark approval of its new Epiducer™ lead delivery system for neurostimulation therapy. Unveiled at the Neurosurgery 2010 Congress in Lyon, France, the Epiducer lead delivery system is the first of its kind, allowing introduction of S-Series perc-paddle leads as well as multiple lead arrays through a single percutaneous entry point.

27 May 2010

Welch Allyn climbs to #35 rank in "The Best Companies to Work For" in Mexico list

For the second consecutive year, The Gestion de Negocios named Welch Allyn, a leading global manufacturer of frontline medical products and solutions, to its list of "The Best Companies to Work For" in Mexico, the country's most comprehensive study of workplace culture. This year's ranking represented a leap of 42 spots, as the company moved from #77 in 2009 to #35 this year—a significant accomplishment for the Welch Allyn de Mexico factory that has only been in operation since 2006.

27 May 2010

TSO3 ships first new 3M Optreoz 125-Z sterilizer with STERIZONE Technology

TSO3 Inc. an innovator in sterilization technology for medical devices in healthcare settings using ozone, announces the shipment of the first new 3M(TM) Optreoz(TM) 125-Z sterilizer with TSO3 STERIZONE(R) Technology.

27 May 2010

Emisphere Technologies announces further extension of Convertible Promissory Note maturity date

Emisphere Technologies, Inc., a biopharmaceutical company that focuses on a unique and improved delivery of pharmaceutical compounds and nutritional supplements using its Eligen® Technology, today announced that Novartis Pharma AG has agreed to further extend the maturity date of Emisphere's Convertible Promissory Note to June 4, 2010.

27 May 2010

Bio-Reference Laboratories second-quarter revenues up 27% to $110,447,000

Bio-Reference Laboratories, Inc. (Numbers in Thousands Except Per Share Data or where otherwise noted) released its second quarter, fiscal year 2010 earnings today for the three months ending April 30. The Company recorded current quarter revenues of $110,447, the best ever quarter in corporate history and an increase of 27% over the $87,183 recorded in the second quarter, fiscal year 2009.

27 May 2010

NOXXON Pharma closes €33 million Series D round of financing

NOXXON Pharma AG, a company focused on the development of mirror image oligonucleotide therapeutics called Spiegelmers®, announced today the successful closing of a €33 million Series D round of financing. The round was led by new investor, NGN Capital, and joined by existing investors TVM Capital, Sofinnova Partners, Edmond de Rothschild Investment Partners, Seventure Partners, VC Fonds Technologie Berlin GmbH, Dow Venture Capital, FCP OP MEDICAL BioHealth-Trends, IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH, the Dieckell Group, and others.

27 May 2010

Active charity supporter nominated for Breast Cancer Campaign's Fundraiser of the Year award

An active charity supporter has been nominated for Breast Cancer Campaign's 'Fundraiser of the Year' award after raising more than £7,500 to help the charity continue funding vital breast cancer research.

27 May 2010

Use of lubricants with anal sex associated with increased risk of rectal sexually transmitted infections

The risk of acquiring HIV through unprotected anal sex is at least 20 times greater than with unprotected vaginal sex and increases if other infections are already present in the rectal lining. Could the use of lubricants - at least certain kinds - be another risk factor among men and women who engage in receptive anal intercourse? Two studies presented today at the International Microbicides Conference in Pittsburgh, suggest the answer is yes.

27 May 2010

Scientists develop inexpensive method for determining chemicals that may cause skin allergies

Scientists are reporting development of a fast, simple, inexpensive method for determining whether chemicals in consumer products and workplaces may cause skin allergies in people -- a method that does not involve use of animals. Their study appears in ACS' Chemical Research in Toxicology, a monthly journal.

27 May 2010

National Science Foundation supports PolyMedix with $150,000 grant for development of antimicrobial sutures

PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat serious acute cardiovascular disorders and infectious diseases, has received a grant in the amount of $150,000 from the National Science Foundation to support the development of antimicrobial sutures. PolyMedix has developed a series of novel antimicrobial polymers for device and material applications, which it collectively calls the PolyCides™.

27 May 2010

$Toremifene reduces fracture risk in men with prostate cancer after initiation of androgen deprivation therapy$

Toremifene reduces fracture risk in men with prostate cancer after initiation of androgen deprivation therapy

GTx, Inc. today announced that additional study results from the Phase III clinical trial evaluating toremifene 80 mg for the prevention of fractures in men with prostate cancer on androgen deprivation therapy will be presented at the 2010 Annual Meeting of the American Urological Association being held in San Francisco May 29-June 3.

27 May 2010

Biomedical/Clinical Engineering practice improves healthcare: Health Association Nova Scotia

The week, May 23 to May 29, is National Biomedical/Clinical Engineering Appreciation Week and celebrations across the country are recognizing the importance of this field to improving healthcare and the contributions of its practitioners.

27 May 2010

Impact of Affordable Care Act on Medicare recipients discussed in Web chat

Marilyn Tavenner, acting administrator and chief operating officer of the Centers for Medicare & Medicaid Services and Caya Lewis, chief of staff at the Centers for Medicare & Medicaid Services will take part in a Web chat Wednesday, May 26, to discuss how America's Medicare recipients will benefit from the Affordable Care Act and discuss how it will reduce costs and give people more control over their health insurance.

27 May 2010

Pressure BioSciences signs CRADA with AFIP, ARP and VA

Pressure BioSciences, Inc. today announced that it has signed a Cooperative Research and Development Agreement ("CRADA") with the Armed Forces Institute of Pathology ("AFIP"), the American Registry of Pathology ("ARP"), and the Department of Veterans Affairs ("VA").

27 May 2010

The Toronto Stock Exchange accepts Cangene's normal course issuer bid

Cangene Corporation announces today that a normal course issuer bid has been accepted by The Toronto Stock Exchange.

27 May 2010

Georgia Tech team wins top three awards in NHIN-CONNECT Code-a-Thon Challenge

Medicity, Inc. - the standard for health information exchange solutions that empower physicians, hospitals and communities to improve care coordination and collaboration - is proud to announce that a team of Georgia Tech students sponsored by Medicity took the top three awards in the recent NHIN-CONNECT Code-a-Thon Challenge in Miami.

27 May 2010

Guadalupe County Hospital to implement Phoenix's Total IT Solution featuring Medsphere's OpenVista EHR

Medsphere Systems Corporation, Phoenix Health Systems and Guadalupe County Hospital today announced Guadalupe's selection of Phoenix's Total IT Solution featuring Medsphere's OpenVista® electronic health record. Phoenix IT expertise paired with Medsphere's open-source EHR solution will enable this 10-bed Santa Rosa, N.M., acute-care hospital to secure federal stimulus support for health IT implementation while improving patient care.

27 May 2010

US District Court dismisses all claims and counterclaims in thalidomide patent cases

Celgene Corporation announced that as a result of Barr Laboratories, Inc., withdrawing its Abbreviated New Drug Application (ANDA) for thalidomide with the US Food and Drug Administration, the US District Court for the District of New Jersey has granted the requested dismissal of all claims and counterclaims in the thalidomide patent cases.

27 May 2010

Local school nominated for Breast Cancer Campaign's School of the Year award

A local school has been nominated for Breast Cancer Campaign's 'School of the Year' award after raising more than £6,500 to help the charity continue funding vital breast cancer research.

27 May 2010

YM BioSciences initiates enrollment in nimotuzumab trial in brain metastases from NSCLC

YM BioSciences Inc., today announced that the first US patient has been enrolled in its randomized, double-blind trial evaluating nimotuzumab in patients with brain metastases from NSCLC at the Florida Cancer Institute - New Hope. This trial initiation follows recent clearance from the US FDA announced on January 26, 2010 allowing the Company to enroll patients at US clinical sites for two of its international and ongoing randomized, double-blind Phase II trials of nimotuzumab.

27 May 2010

Medical News

St. Jude Medical's Epiducer lead delivery system for neurostimulation therapy receives CE Mark approval

Welch Allyn climbs to #35 rank in "The Best Companies to Work For" in Mexico list

TSO3 ships first new 3M Optreoz 125-Z sterilizer with STERIZONE Technology

Emisphere Technologies announces further extension of Convertible Promissory Note maturity date

Bio-Reference Laboratories second-quarter revenues up 27% to $110,447,000

NOXXON Pharma closes €33 million Series D round of financing

Active charity supporter nominated for Breast Cancer Campaign's Fundraiser of the Year award

Use of lubricants with anal sex associated with increased risk of rectal sexually transmitted infections

Scientists develop inexpensive method for determining chemicals that may cause skin allergies

National Science Foundation supports PolyMedix with $150,000 grant for development of antimicrobial sutures

Toremifene reduces fracture risk in men with prostate cancer after initiation of androgen deprivation therapy

Biomedical/Clinical Engineering practice improves healthcare: Health Association Nova Scotia

Impact of Affordable Care Act on Medicare recipients discussed in Web chat

Pressure BioSciences signs CRADA with AFIP, ARP and VA

The Toronto Stock Exchange accepts Cangene's normal course issuer bid

Georgia Tech team wins top three awards in NHIN-CONNECT Code-a-Thon Challenge

Guadalupe County Hospital to implement Phoenix's Total IT Solution featuring Medsphere's OpenVista EHR

US District Court dismisses all claims and counterclaims in thalidomide patent cases

Local school nominated for Breast Cancer Campaign's School of the Year award

YM BioSciences initiates enrollment in nimotuzumab trial in brain metastases from NSCLC

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News